performances Comparison is as follows: (Unit : Thousand Baht) Consolidate F/S Q3/2017 Q3/2016 Δ% Q2/2017 Δ% Q1/2017 Δ% Revenues from sales and services 802,230 855,852 -6% 704,817 14% 870,845 -8% Interest income

reported revenue growth of 38.4% y-y or THB 346 million, driven primarily by business combination. Excluding TBSP, Company’s core revenues increased by 12.5% or THB 78 mil, mainly caused by higher revenues

7.5% or THB 25 mil from q-q, mainly caused by higher revenues from Business Form and Office Paper. Revenue Breakdown Mil THB 337 362.1 266 262.0 0.3 Q3 18 Q3 19 624.4 + 3.6% 603 +7.5% - 1.4% +100.0

level as the previous quarter. This was mainly contributed from an increase in credit card income by 14%, personal loan income by 15% and other incomes in bad debt recovery and collection service income

) 12.46 117.19 Income tax (expense) revenue 0.66 0.26 0.40 150.84 1.31 0.38 0.93 248.16 Profit (Loss) for the year (15.50) (2.74) 8.76 320.08 (21.79) (10.26) 11.53 112.39 Other comprehensive (expense) for

) (42.58) Income tax (expense) revenue 0.26 (0.30) (0.56) (188.72) 0.38 (1.82) (2.19) (120.72) Profit (loss) for the year (2.74) (5.46) (2.72) (49.81) (10.26) (20.34) (10.08) (49.55) Other comprehensive

(96.47) (10.86) (24.73) 13.88 (56.11) Income tax (expense) revenue 0.25 (0.94) 1.19 (126.48) 0.63 (2.76) 3.38 (122.69) Profit (loss) for the year 0.03 (7.15) 7.18 (100.42) (10.23) (27.49) 17.26 (62.79

risks as basis for determining how the risk should be managed. Questions Yes No 7.1 The company identifies all risks which may affect business operation at levels of organization, business unit

medicines, expanding various product types, increasing revenue and reducing costs Agenda 4 To consider and approve the issuance and offering of debentures in an amount not exceeding 300 million Baht. The

is based on the consolidated financial statements of the Company and TSE, comprising statements of financial position as at 30 September 2017 and statements of comprehensive income for the year ended